FDA in the process of hiring more than 1k new scientists to speed up drug reviews, according to Bloomberg
Context
The FDA's plan to hire over 1,000 new scientists indicates a significant commitment to accelerating drug reviews, which could streamline the approval process for new pharmaceuticals. This move may enhance investor confidence in biotech and pharmaceuticals, potentially impacting related stocks as well as broader market sentiment surrounding healthcare innovation.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#FDA#EU SESSION#US SESSION#US EQUITIES